Zinereo Pharma at Vitafoods Europe 2026: Unveiling a New Vision of Microbiome-Driven Health
This past May, Zinereo Pharma was present at Vitafoods Europe 2026 in Barcelona, one of the leading global events in nutraceuticals and microbiome innovation, where science, business, and future healthcare solutions converged.
At our stand, we presented a renewed, science-driven portfolio built around three key microbiome axes that are transforming health from the inside out:
Three axes, one common ground: health starts in the gut.
- Gut–Respiratory Axis
- Gut–Women’s Health Axis
- Gut–Immune Axis
As part of this evolution, we showcased our Gut–Respiratory Axis, highlighting new solutions such as:
- Otibiome®: a clinically evaluated probiotic approach for the prevention of Acute Otitis Media in children.
- Pharmalactis Breathe®: a postbiotic solution for upper respiratory tract management.
Our space became the ideal meeting point to discover how this new approach connects science, innovation, and real business opportunities within the global microbiome ecosystem.
Zinereo Pharma extends its most sincere gratitude to all the visitors, strategic partners, and industry professionals who gathered at our stand in Barcelona. Your valuable presence and the excellent reception of our portfolio reinforce our commitment to continue leading the future of healthcare through science and innovation.
